8
Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation in the Internet2 Community May 7, 2002

Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation

Embed Size (px)

Citation preview

Page 1: Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation

Celeste F. Bové, M.A., CCC-ASenior Science Policy Analyst

Office of Science Coordination & CommunicationFood and Drug Administration

FDA Participation in the Internet2

Community

May 7, 2002

Page 2: Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation

2

FDA Organization

Center for Biologics Evaluation and Research

Center for Devices and Radiological Health

Center for Drug Evaluation and Research

Center for Food Safety and Applied Nutrition

Center for Veterinary Medicine

National Center for Toxicological Research

Office of Regulatory Affairs

Office of the Commissioner

Page 3: Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation

3

FDA Regulatory Science Focus

Public health questionsBetter tools and methods

New science, new technologiesInformation managementAdeptness of scientific workforceConsumer information

Page 4: Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation

4

New Science - New Technologies

Genomics, proteomics

Tissue products

Robotics

Biosensors, drug delivery systems

Transgenics

Page 5: Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation

5

Information Management

Informatics

Artificial intelligence tools

Knowledge/ data

management

Computational science

Risk Management

Page 6: Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation

6

FDA - A Scientific Agency

Training, retraining

Communication among

scientists

Page 7: Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation

7

Consumer Information

Freedom of choice, right to know

Risk communication

Page 8: Celeste F. Bové, M.A., CCC-A Senior Science Policy Analyst Office of Science Coordination & Communication Food and Drug Administration FDA Participation

8

Internet2 - Current Status

Ramp-up stage, i.e., disseminate information across the agency

Facilitate communication between and among interested scientists

Identify potential uses for Internet2 technology

Identify regulatory implications

Assess value to agency